Christina Ciaramitaro
Clinical Trial Coordinator for the TIMI Study Group
- Role
- Clinical Trial Coordinator at Timi Study Group
- Location
- Boston, MA, US
- LinkedIn followers
- 500 followers
About Christina Ciaramitaro
Clinical Trial Coordinator working on various global clinical trials to advance…
Experience
Clinical Trial Coordinator
Jul 2024 — Present · Boston, MA, US
The TIMI Study Group is an Academic Research Organization of Brigham & Women\'s Hospital and an affiliate of Harvard Medical School. The group works alongside pharmaceutical companies to provide innovative clinical trials that enhance the understanding of cardiovascular disease and improve the care of patients.Trials Worked: CORE CS5: Phase 3 multicenter, randomized, double-blind, placebo-controlled trial of ~450 patients to evaluate the safety and efficacy of ISIS 678354, an antisense oligonucleotide inhibitor of production, administered subcutaneously to patients with severe hypertriglyceridemia.CORE2 CS6: Phase 3 multicenter, randomized, double-blind, placebo-controlled trial in ~390 patients to evaluate the safety and efficacy of Olezarsen, an antisense oligonucleotide inhibitor of production, administered subcutaneously to patients with severe hypertriglyceridemia.CS15: ISIS 678354-CS15 is a multi-center, open-label study of up to 700 participants with SHTG who would be rolled over from studies ISIS 678354-CS5 CORE or ISIS 678354-CS6 CORE2. The purpose of this study is to evaluate the safety and tolerability of Olezarsen in participants with SHTG.Essence CS9: Phase 3 multicenter, randomized, double-blind, placebo-controlled trial in ~1320 patients to evaluate the safety and efficacy of Olezarsen, an antisense oligonucleotide inhibitor of production, administered subcutaneously to patients with either moderate hypertriglyceridemia and atherosclerotic cardiovascular disease (established or at increased risk for) or with severe hypertriglyceridemia.OCEAN(a) Outcomes: Evaluating the efficacy and safety of lowering lipoprotein(a) through RNA interference with Olpasiran in participants with atherosclerotic cardiovascular disease and elevated lipoprotein(a) concentrations.
Education
Gloucester High School
General Studies
2015 — 2019
University of Massachusetts Lowell
Bachelor of Science - BS
2019 — 2023
University of Massachusetts Lowell
Master of Science - MS
2023 — 2024
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.